Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Chan

Showing results (41-50 of 164) with videos related to

Pageof 17
Sort By:
Cancer Research|February 6, 2019
Genome-Wide Screening and Functional Analysis Identifies Tumor Suppressor Long Noncoding RNAs Epigenetically Silenced in Hepatocellular CarcinomaFeiyue Xu, Chi Han Li, Chi Hin Wong, et al.
Investigational New Drugs|January 28, 2009
The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell linesBrigette B Y Ma, Fion Sung, Qian Tao, et al.
Journal of Hepatology|April 3, 2024
Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatmentStephen L Chan, Baek-Yeol Ryoo, Frankie Mo, et al.
Journal of Gastroenterology and Hepatology|May 14, 2015
Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinomaStephen L Chan, Frankie Mo, Philip Johnson, et al.
Human Vaccines & Immunotherapeutics|March 10, 2025
Prevention of herpes zoster in acquired immunocompromised conditions: Review of updates and perspectives from Hong KongDesmond Y H Yap, Gordon C K Chan, So Ho, et al.
Cancer Research|September 14, 2014
A small-molecule modulator of the tumor-suppressor miR34a inhibits the growth of hepatocellular carcinomaZhangang Xiao, Chi Han Li, Stephen L Chan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 15, 2024
Organ-specific responses to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma: A multicentre, retrospective studyJaekyung Cheon, Sanghoon Jung, Jung Sun Kim, et al.
British Journal of Cancer|January 13, 2017
Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillancePhilip Johnson, Sarah Berhane, Chiaki Kagebayashi, et al.
Frontiers in Oncology|September 12, 2025
<i>ISG15</i> mRNA transcript level in circulating leucocytes prognostic of overall survival in hepatocellular carcinoma patients and correlated with quality of life disturbances involved in anorexia-cachexiaLeung Li, Nelson L S Tang, Frankie Mo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 23, 2019
Biology and significance of alpha-fetoprotein in hepatocellular carcinomaPeter R Galle, Friedrich Foerster, Masatoshi Kudo, et al.
Pageof 17

Showing results (41-50 of 164) with videos related to

Sort By:
Pageof 17
Cancer Research|February 6, 2019
Genome-Wide Screening and Functional Analysis Identifies Tumor Suppressor Long Noncoding RNAs Epigenetically Silenced in Hepatocellular CarcinomaFeiyue Xu, Chi Han Li, Chi Hin Wong, et al.
Investigational New Drugs|January 28, 2009
The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell linesBrigette B Y Ma, Fion Sung, Qian Tao, et al.
Journal of Hepatology|April 3, 2024
Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatmentStephen L Chan, Baek-Yeol Ryoo, Frankie Mo, et al.
Journal of Gastroenterology and Hepatology|May 14, 2015
Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinomaStephen L Chan, Frankie Mo, Philip Johnson, et al.
Human Vaccines & Immunotherapeutics|March 10, 2025
Prevention of herpes zoster in acquired immunocompromised conditions: Review of updates and perspectives from Hong KongDesmond Y H Yap, Gordon C K Chan, So Ho, et al.
Cancer Research|September 14, 2014
A small-molecule modulator of the tumor-suppressor miR34a inhibits the growth of hepatocellular carcinomaZhangang Xiao, Chi Han Li, Stephen L Chan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 15, 2024
Organ-specific responses to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma: A multicentre, retrospective studyJaekyung Cheon, Sanghoon Jung, Jung Sun Kim, et al.
British Journal of Cancer|January 13, 2017
Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillancePhilip Johnson, Sarah Berhane, Chiaki Kagebayashi, et al.
Frontiers in Oncology|September 12, 2025
<i>ISG15</i> mRNA transcript level in circulating leucocytes prognostic of overall survival in hepatocellular carcinoma patients and correlated with quality of life disturbances involved in anorexia-cachexiaLeung Li, Nelson L S Tang, Frankie Mo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 23, 2019
Biology and significance of alpha-fetoprotein in hepatocellular carcinomaPeter R Galle, Friedrich Foerster, Masatoshi Kudo, et al.
Pageof 17